Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bayer, Deutsches Krebsforschungszentrum present new MAP4K1 inhibitors

May 10, 2021

PTPN11 inhibitors discovered at Hangzhou Rex Pharmaceutical

May 10, 2021

Lead Pharma Holding presents new ERR-alpha inverse agonists

May 10, 2021

PEP-010 enters first-in-human study in solid tumors

May 10, 2021

PLEK2 as prognostic biomarker and therapeutic target in ESCC

May 7, 2021

China NMPA grants conditional approval to pamiparib for advanced ovarian cancer

May 7, 2021

Phase II trial shows improved PFS when relacorilant is added to nab-paclitaxel in ovarian cancer

May 7, 2021

Betta Pharmaceuticals synthesizes EGFR inhibitors

May 7, 2021

IMPACT Therapeutics identifies new Wee1 inhibitors

May 7, 2021

DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative

May 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026